Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

PAK1/2/3 anticorps (pThr423)

PAK1/2/3 Reactivité: Humain IHC, ELISA, WB Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN105217
  • Antigène Voir toutes PAK1/2/3 Anticorps
    PAK1/2/3 (P21-Activated Kinases 1/2/3 (PAK1/2/3))
    Épitope
    • 12
    • 12
    • 11
    • 11
    • 7
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pThr423
    Reactivité
    • 34
    • 27
    • 26
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 35
    Lapin
    Clonalité
    • 33
    • 2
    Polyclonal
    Conjugué
    • 28
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp PAK1/2/3 est non-conjugé
    Application
    • 20
    • 19
    • 18
    • 6
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Immunohistochemistry (IHC), ELISA, Western Blotting (WB)
    Attributs du produit
    Concentration Definition: by UV absorbance at 280 nm
    Immunogène
    Human PAK 1/2/3 phospho peptide corresponding to a region of the human protein conjugated to Keyhole Limpet Hemocyanin (KLH).
    Isotype
    IgG
    Top Product
    Discover our top product PAK1/2/3 Anticorps primaire
  • Indications d'application
    This phospho specific polyclonal antibody was tested by ELISA and was found to be reactive with the phosphorylated form of the immunizing peptide and minimally reactive with the non-phosphorylated form of the immunizing peptide.   Although not tested, this antibody is likely functional in immunohistochemistry, immunoblotting, and immuno-precipitation.  Lysates from Jurkat cells or PAK transfected cells may be used as a control.This product has been assayed against 0.1 µg of phosphorylated peptide in a standard capture ELISA using TMB (3,3',5,5'-Tetramethylbenizidine) as a substrate for 30 minutes at room temperature.  A working dilution of 1:5,000 to 1:25,000 is suggested for this product.  Less than 0.2% cross-reactivity was detected against the non-phosphorylated form o f the immunizing peptide.  Researchers should determine optimal titers for other applications. This product has been assayed against 0.1 µg of phosphorylated peptide in a standard capture ELISA using TMB (3,3',5,5'-Tetramethylbenizidine) should determine optimal titers for other applications. This product has been assayed against 0.1 µg of phosphorylated peptide in a standard capture ELISA using TMB (3,3',5,5'-Tetramethylbenizidine) as a substrate for 30 minutes at room temperature.  A working dilution of 1:5,000 to 1:25,000 is suggested for this product.  Less than 0.2% cross-reactivity was detected against the non-phosphorylated form o f the immunizing peptide.  Researchers should determine optimal titers for other applications. This product has been assayed against 0.1 µg of phosphorylated peptide in a standard capture ELISA using TMB (3,3',5,5'-Tetramethylbenizidine) as a substrate for 30 minutes at room temperature.  A working dilution of 1:5,000 to 1:25,000 is suggested for this product.  Less than 0.2% cross-reactivity was detected against the non-phosphorylated form o f the immunizing peptide.  Researchers should determine optimal titers for other applications. This product has been assayed against 0.1 µg of phosphorylated peptide in a standard capture ELISA using TMB (3,3',5,5'-Tetramethylbenizidine) as a substrate for 30 minutes at room temperature.  A working dilution of 1:5,000 to 1:25,000 is suggested for this product.  Less than 0.2% cross-reactivity was detected against the non-phosphorylated form o f the immunizing peptide.  Researchers should determine optimal titers for other applications.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1.94 mg/mL
    Buffer
    0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
  • Antigène
    PAK1/2/3 (P21-Activated Kinases 1/2/3 (PAK1/2/3))
    Autre désignation
    PAK 1/2/3 (PAK1/2/3 Produits)
    Synonymes
    anticorps X-PAK1, anticorps XPak1, anticorps pak, anticorps pak-1, anticorps pakalpha, anticorps p21 protein (Cdc42/Rac)-activated kinase 1 S homeolog, anticorps p21 (RAC1) activated kinase 1, anticorps pak1.S, anticorps PAK1
    Sujet
    The p21-activated kinases (PAKs) are a family of multifunctional serine/threonine kinases involved in a variety of cell functions including stress response, apoptosis and regulation of cell motility and tumor metastasis.  Mammalian PAKs are called 1, 2, 3 or a, g, b respectively.  PAKs are part of a large family of kinases where the catalytic domain of the kinase is related to Ste20 kinase of S. cerevisiae.  Pak activity is regulated by specific binding of GTP-bound Rac and cdc42 GTPases and also by sphingosine and related lipids.  PAK1 activation is induced by a variety of growth factors and G-protein-coupled receptors, Fc receptors, and integrins.  This antibody is specific for the phosphorylated form of PAK 1/2/3.  The selected peptide sequence used to generate the polyclonal antibody is common to all human PAKs.
    Synonyms: Alpha PAK antibody, Gamma PAK antibody, Beta PAK antibody
    ID gène
    5058
    UniProt
    Q13153
Vous êtes ici:
Support technique